Last reviewed · How we verify
NCT04164355
Study of Retinal and Choriocapillary Vascular Changes in Patients Undergoing Tadalafil 20mg
trial testing Tadalafil 20 MG in Erectile Dysfunction Following Radical Prostatectomy in 40 participants. Completed in 30 April 2021.
25 April 2021
Quick facts
| Lead sponsor | Federico II University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 4 July 2020 |
| Primary completion | 25 April 2021 |
| Estimated completion | 30 April 2021 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Tadalafil 20 MG — full drug profile →
Conditions studied
- Erectile Dysfunction Following Radical Prostatectomy — all drugs for Erectile Dysfunction Following Radical Prostatectomy →
Sponsor
Federico II University
Who can join
Adults 45 to 80, male only, with Erectile Dysfunction Following Radical Prostatectomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates the retinal and choriocapillary vascular features in patients under the effects of Tadalafil 20mg using optical coherence tomography angiography.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04164355
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Tadalafil 20 MG
Trials testing the same drug.
- NCT05709574 — Tadalafil Effect + Chemotherapy in Resectable Gastric/GEJ Cancer · Phase 2 · recruiting
- NCT04684589 — Effect of PDE5 Inhibition on Adipose Metabolism in Humans · Phase 2 · completed
- NCT04491773 — Study of Retinal and Choriocapillary Vascular Changes in Patients Undergoing Tadalafil 20mg for More Than 6 Months · completed
- NCT03905018 — Effect of Tadalafil Administration on Vasodilatation Mediated by Flow in Patients With Obesity Grade I-II · Phase 3 · unknown
- NCT02653833 — The Study of Skeletal Muscle Blood Flow in Becker Muscular Dystrophy · EARLY_PHASE1 · terminated
Other recruiting trials for Erectile Dysfunction Following Radical Prostatectomy
Currently open trials in the same condition.
- NCT07520916 — The Effect of Mobile-Based Perioperative Education on Urinary Incontinence and Erectile Function After Radical Prostatec · NA · recruiting
- NCT06605508 — Regenerative Injection of Stem Cells or Stem Cell-derived Exosomes for Erectile Dysfunction (RISE) · recruiting
- NCT07101731 — Effects of Hypopressive Exercises on Urinary Incontinence and Erectile Dysfunction After Radical Prostatectomy · NA · recruiting
- NCT06875258 — PEnile ReHABilitation After Nerve Sparing Robot-assisted Radical Prostatectomy for Prostate Cancer 2.0 (PEHAB-II) · Phase 4 · recruiting
- NCT05558007 — Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients · Phase 2 · recruiting
Other Federico II University trials
Trials by the same sponsor.
- NCT07437690 — Fall Prevention in Older Adults in an Italian Cohort · not yet recruiting
- NCT07282132 — Evaluation of Real-World Data on Ropeginterferon Alfa-2b in Patients With Polycythemia Vera: Insights From a Multicenter · not yet recruiting
- NCT07280286 — Incidence of Intrauterine Adhesions After Myomectomy With Intrauterine Anti-Adhesion Gel · NA · not yet recruiting
- NCT07374861 — Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Bempedoic Acid in Italy · recruiting
- NCT07314684 — GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04164355 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Federico II University
- Last refreshed: 24 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04164355.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing